Akigin Capital Partners
Overview
Akigin Capital Partners is a Japanese private equity firm specializing in investments in small and medium-sized enterprises (SMEs). The firm is a subsidiary of Akita Bank, reflecting its strong ties to the local financial sector. The firm's investment strategy encompasses various stages, including Seed, Series A, Series B, and Growth phases. Akigin Capital Partners primarily focuses on sectors such as Healthcare, Health Diagnostics, and Medical industries. The firm has a geographical focus on Japan, aligning with its commitment to supporting domestic SMEs. Akigin Capital Partners has demonstrated active investment activity, with a notable investment in Cranebio, a company specializing in Health Care, Health Diagnostics, and Medical sectors, in October 2023. The firm typically invests around $2 million per deal, indicating a preference for early-stage ventures. This approach underscores Akigin Capital Partners' dedication to fostering growth and innovation within Japan's SME landscape.
Investment Focus
- Focus on small and medium-sized enterprises in Japan
- Sectors: Healthcare, Health Diagnostics, Medical
- Investment size around $2 million per deal
Portfolio Companies
Reach Akigin Capital Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Akigin Capital Partners
What sectors does Akigin Capital Partners invest in?
Akigin Capital Partners invests in Healthcare, Medical and Health Diagnostics, and is based in Japan. Akigin Capital Partners is listed as a private equity in the ConnectSafely investor database.
What stage does Akigin Capital Partners invest at?
Akigin Capital Partners backs companies at Seed, Series A, Series B and Growth, writing cheques of 2M - 2M.
Which regions does Akigin Capital Partners invest in?
Akigin Capital Partners invests across Japan.
What companies has Akigin Capital Partners invested in?
Akigin Capital Partners's portfolio includes Cranebio.
Last updated · Source: ConnectSafely investor database
